Cargando…
Striatal TRPV1 activation by acetaminophen ameliorates dopamine D(2) receptor antagonist–induced orofacial dyskinesia
Antipsychotics often cause tardive dyskinesia, an adverse symptom of involuntary hyperkinetic movements. Analysis of the US Food and Drug Administration Adverse Event Reporting System and JMDC insurance claims revealed that acetaminophen prevented the dyskinesia induced by dopamine D(2) receptor ant...
Autores principales: | Nagaoka, Koki, Nagashima, Takuya, Asaoka, Nozomi, Yamamoto, Hiroki, Toda, Chihiro, Kayanuma, Gen, Siswanto, Soni, Funahashi, Yasuhiro, Kuroda, Keisuke, Kaibuchi, Kozo, Mori, Yasuo, Nagayasu, Kazuki, Shirakawa, Hisashi, Kaneko, Shuji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262333/ https://www.ncbi.nlm.nih.gov/pubmed/33857021 http://dx.doi.org/10.1172/jci.insight.145632 |
Ejemplares similares
-
Enhancement of adenosine A(2A) signaling improves dopamine D(2) receptor antagonist-induced dyskinesia via β-arrestin signaling
por: Nagaoka, Koki, et al.
Publicado: (2023) -
Early Detection of Adverse Drug Reaction Signals by Association Rule Mining Using Large-Scale Administrative Claims Data
por: Yamamoto, Hiroki, et al.
Publicado: (2023) -
Drug Repurposing Prediction and Validation From Clinical Big Data for the Effective Treatment of Interstitial Lung Disease
por: Siswanto, Soni, et al.
Publicado: (2021) -
Orofacial Dyskinesia in Uremia in Polycystic Kidney Disease
por: Arora, Nidhi, et al.
Publicado: (2023) -
Modification of TRPV4 activity by acetaminophen
por: Nakagawa, Fumio, et al.
Publicado: (2020)